<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>damgalama) &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/damgalama/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 25 Jan 2026 15:44:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>damgalama) &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Exploring Barriers and Supports for Buprenorphine in Ontario</title>
		<link>https://bioengineer.org/exploring-barriers-and-supports-for-buprenorphine-in-ontario/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 25 Jan 2026 15:44:34 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[damgalama)]]></category>
		<category><![CDATA[düzenlemeler]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Buprenorfin tedavisi]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket: **Buprenorfin Engelleri]]></category>
		<category><![CDATA[Nitel araştırma** * **Buprenorfin tedavisi:** Makalenin ana konusu. * **Tedavi engelleri:** Çalışmanın temel odağı (stigma]]></category>
		<category><![CDATA[Ontario Sağlık Politikası]]></category>
		<category><![CDATA[Ontario'da]]></category>
		<category><![CDATA[Opioid Kullanım Bozukluğu Tedavisi]]></category>
		<category><![CDATA[Sağlık Çalışanı Damgalaması]]></category>
		<category><![CDATA[Tedavi engelleri]]></category>
		<category><![CDATA[Teorik Alanlar Çerçevesi** * **Buprenorfin Engelleri:** İçeriğin ana odağı]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-barriers-and-supports-for-buprenorphine-in-ontario/</guid>

					<description><![CDATA[In the realm of opioid addiction treatment, buprenorphine has emerged as a vital tool in the arsenal against substance dependence. However, its acceptance and application within healthcare systems vary significantly. A recent qualitative study conducted in Ontario, Canada, sheds light on the multifaceted barriers and facilitators associated with the use of buprenorphine, providing insights crucial [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320731</post-id>	</item>
		<item>
		<title>Why Pregnant Women in Ghana Skip Cervical Screening</title>
		<link>https://bioengineer.org/why-pregnant-women-in-ghana-skip-cervical-screening/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 18 Nov 2025 15:51:35 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[and barriers)]]></category>
		<category><![CDATA[Andersen behavioral model]]></category>
		<category><![CDATA[Andersen Behavioural Model]]></category>
		<category><![CDATA[Based on the content]]></category>
		<category><![CDATA[Behavior]]></category>
		<category><![CDATA[damgalama)]]></category>
		<category><![CDATA[focusing on the core themes (location]]></category>
		<category><![CDATA[Ghana maternal health]]></category>
		<category><![CDATA[health issue]]></category>
		<category><![CDATA[healthcare barriers Ghana]]></category>
		<category><![CDATA[here are 5 appropriate tags: **cervical cancer screening in Ghana]]></category>
		<category><![CDATA[Low-resource settings health disparities** * **Cervical cancer screening barriers:** Makale taramaya katılımın önündeki engelleri (bilgi eksikliği]]></category>
		<category><![CDATA[Makalenin içeriğine göre en uygun 5 etiket: **Cervical cancer screening barriers]]></category>
		<category><![CDATA[model]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[Pregnancy healthcare access]]></category>
		<category><![CDATA[pregnant women non-screening]]></category>
		<category><![CDATA[sistemik sorunlar]]></category>
		<category><![CDATA[sosyoekonomik faktörler]]></category>
		<guid isPermaLink="false">https://bioengineer.org/why-pregnant-women-in-ghana-skip-cervical-screening/</guid>

					<description><![CDATA[In the ongoing battle against cervical cancer, a new study from Ghana sheds critical light on why a significant majority of pregnant women remain unscreened, despite repeated opportunities to engage with healthcare systems. Cervical cancer continues to be a devastating cause of mortality, particularly in low- and middle-income countries, where screening programs are less accessible [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">298311</post-id>	</item>
	</channel>
</rss>
